Insulin icodec is a once-weekly basal insulin that may improve treatment acceptance and adherence by reducing the number of basal insulin injections from at least 365 per year to 52 per year.3 Clinical trials have demonstrated that icodec has a long half-life of approximately 1 week, with phas...
How you spend the rest of the week? That's up to you. ||In a study, 94% of adults with type 2 diabetes who used the Trulicity pen found it easy to use. Before starting Trulicity, your healthcare provider should show you how to use the pen. ...
Gan & Lee Pharmaceuticals also announced announced that a multicenter, randomized, open-label, parallel-control, treat-to-target phase 2 study is underway in patients with T2DM who have inadequate glycemic control with oral antidiabetic drugs, including insulin-naïve patients and patients on basal ...
once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults J van Can1, B Sloth2, CB Jensen2, A Flint2, EE Blaak1 and WHM Saris1 INTRODUCTION: Mechanisms for liraglutide-induced weight loss are poorly understood....
Do you have other medical conditions, including problems with your pancreas, kidneys, liver, or stomach, or have a history of diabetic retinopathy (vision problems related to diabetes)? Do you take other diabetes medicines, such as insulin or sulfonylureas?